sumatriptan has been researched along with Brachial Paresis in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novitskaya, ES | 1 |
| Cates, CA | 1 |
| Bowes, OM | 1 |
| Vivian, AJ | 1 |
1 other study available for sumatriptan and Brachial Paresis
| Article | Year |
|---|---|
Triptans and third nerve paresis: a case series of three patients.
Topics: Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Oculomotor Nerve Diseases; Paresis; Sum | 2017 |